Paper12379721
Immunization with C5a peptidase or peptidase-type III polysaccharide conjugate vaccines enhances clearance of group B Streptococci from lungs of infected mice.
Cheng Q and 7 others. Infect Immun, 2002. Cited by 42 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Immunization with C5a peptidase or peptidase-type III polysaccharide conjugate vaccines enhances clearance of group B Streptococci from lungs of infected mice. Papers, record 12379721. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/12379721
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Adhesins, Bacterial | Major topic |
| Endopeptidases | Major topic |
| Lung | Major topic |
| Polysaccharides, Bacterial | Major topic |
| Streptococcal Infections | Major topic |
| Streptococcal Vaccines | Major topic |
| Streptococcus agalactiae | Major topic |
| Animals | |
| Blood Bactericidal Activity | |
| Female | |
| Immunization | |
| Mice | |
| Phagocytosis | |
| Serotyping | |
| Vaccines, Conjugate |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| AI2006 | NIAID NIH HHS | United States | PubMed |
Source PubMed
References35
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 9,841,833 | Safety and immunogenicity of capsular polysaccharide-tetanus toxoid conjugate vaccines for group B streptococcal types Ia and Ib. | J Infect Dis | 1999 | https://conductscience.org/library/papers/9841833 | PubMed |
| 2 | 9,784,550 | Impact of M49, Mrp, Enn, and C5a peptidase proteins on colonization of the mouse oral mucosa by Streptococcus pyogenes. | Infect Immun | 1998 | https://conductscience.org/library/papers/9784550 | PubMed |
| 3 | 10,189,305 | 1997 AAP guidelines for prevention of early-onset group B streptococcal disease. | Pediatrics | 1999 | https://conductscience.org/library/papers/10189305 | PubMed |
| 4 | 10,225,912 | Alpha C protein as a carrier for type III capsular polysaccharide and as a protective protein in group B streptococcal vaccines. | Infect Immun | 1999 | https://conductscience.org/library/papers/10225912 | PubMed |
| 5 | 14,461,914 | Current knowledge of type-specific M antigens of group A streptococci. | J Immunol | 1962 | https://conductscience.org/library/papers/14461914 | PubMed |
| 6 | 10,713,053 | Characterization of the linkage between the type III capsular polysaccharide and the bacterial cell wall of group B Streptococcus. | J Biol Chem | 2000 | https://conductscience.org/library/papers/10713053 | PubMed |
| 7 | 10,809,707 | Characterization of the streptococcal C5a peptidase using a C5a-green fluorescent protein fusion protein substrate. | J Bacteriol | 2000 | https://conductscience.org/library/papers/10809707 | PubMed |
| 8 | 10,948,119 | Genetic polymorphisms of group B streptococcus scpB alter functional activity of a cell-associated peptidase that inactivates C5a. | Infect Immun | 2000 | https://conductscience.org/library/papers/10948119 | PubMed |
| 9 | 11,115,709 | Preparation and preclinical evaluation of experimental group B streptococcus type III polysaccharide-cholera toxin B subunit conjugate vaccine for intranasal immunization. | Vaccine | 2000 | https://conductscience.org/library/papers/11115709 | PubMed |
| 10 | 11,254,587 | Antibody against surface-bound C5a peptidase is opsonic and initiates macrophage killing of group B streptococci. | Infect Immun | 2001 | https://conductscience.org/library/papers/11254587 | PubMed |
| 11 | 11,953,377 | The group B streptococcal C5a peptidase is both a specific protease and an invasin. | Infect Immun | 2002 | https://conductscience.org/library/papers/11953377 | PubMed |
| 12 | 12,010,974 | Identification of novel adhesins from Group B streptococci by use of phage display reveals that C5a peptidase mediates fibronectin binding. | Infect Immun | 2002 | https://conductscience.org/library/papers/12010974 | PubMed |
| 13 | 1,105,186 | A comparison of early-onset group B streptococcal neonatal infection and the respiratory-distress syndrome of the newborn. | N Engl J Med | 1976 | https://conductscience.org/library/papers/1105186 | PubMed |
| 14 | 768,760 | Correlation of maternal antibody deficiency with susceptibility to neonatal group B streptococcal infection. | N Engl J Med | 1976 | https://conductscience.org/library/papers/768760 | PubMed |
| 15 | 57,196 | Pulmonary changes in neonatal sepsis to group B beta-hemolytic Streptococcus: relation of hyaline membrane disease. | J Infect Dis | 1976 | https://conductscience.org/library/papers/57196 | PubMed |
| 16 | 344,223 | Adult mice as a model for early onset group B streptococcal disease. | Infect Immun | 1978 | https://conductscience.org/library/papers/344223 | PubMed |
| 17 | 3,898,306 | Group B streptococcal vaccines. | Rev Infect Dis | 1985 | https://conductscience.org/library/papers/3898306 | PubMed |
| 18 | 3,053,900 | Group B streptococci inhibit the chemotactic activity of the fifth component of complement. | J Immunol | 1988 | https://conductscience.org/library/papers/3053900 | PubMed |
| 19 | 2,243,123 | Immunogenicity in animals of a polysaccharide-protein conjugate vaccine against type III group B Streptococcus. | J Clin Invest | 1990 | https://conductscience.org/library/papers/2243123 | PubMed |
| 20 | 1,996,961 | Group B streptococci inactivate complement component C5a by enzymic cleavage at the C-terminus. | Biochem J | 1991 | https://conductscience.org/library/papers/1996961 | PubMed |
Cited by22
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 42 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,226,151 | CRISPR-Cas9-mediated construction of a Streptococcus agalactiae vaccine for tilapia and evaluation of its protective efficacy. | BMC Vet Res | 2026 | https://conductscience.org/library/papers/42226151 | PubMed |
| 38,258,026 | Immunomodulating Enzymes from Streptococcus pyogenes-In Pathogenesis, as Biotechnological Tools, and as Biological Drugs. | Microorganisms | 2024 | https://conductscience.org/library/papers/38258026 | PubMed |
| 36,006,736 | Mast cell-derived factor XIIIA contributes to sexual dimorphic defense against group B streptococcal infections. | J Clin Invest | 2022 | https://conductscience.org/library/papers/36006736 | PubMed |
| 35,608,349 | Virulence Factor Genes and Cytotoxicity of Streptococcus agalactiae Isolated from Bovine Mastitis in Poland. | Microbiol Spectr | 2022 | https://conductscience.org/library/papers/35608349 | PubMed |
| 35,055,991 | Immunogenic Proteins of Group B Streptococcus-Potential Antigens in Immunodiagnostic Assay for GBS Detection. | Pathogens | 2021 | https://conductscience.org/library/papers/35055991 | PubMed |
| 34,649,250 | The Role of Streptococcal Cell-Envelope Proteases in Bacterial Evasion of the Innate Immune System. | J Innate Immun | 2022 | https://conductscience.org/library/papers/34649250 | PubMed |
| 30,566,365 | The Streptococcus agalactiae complement interfering protein combines multiple complement-inhibitory mechanisms by interacting with both C4 and C3 ligands. | FASEB J | 2019 | https://conductscience.org/library/papers/30566365 | PubMed |
| 29,995,578 | Progress toward a group B streptococcal vaccine. | Hum Vaccin Immunother | 2018 | https://conductscience.org/library/papers/29995578 | PubMed |
| 26,602,918 | Adjuvant Immune Enhancement of Subunit Vaccine Encoding pSCPI of Streptococcus iniae in Channel Catfish (Ictalurus punctatus). | Int J Mol Sci | 2015 | https://conductscience.org/library/papers/26602918 | PubMed |
| 26,288,735 | Group B Streptococcus vaccine: state of the art. | Ther Adv Vaccines | 2015 | https://conductscience.org/library/papers/26288735 | PubMed |
| 25,492,846 | Non-proteolytic functions of microbial proteases increase pathological complexity. | Proteomics | 2015 | https://conductscience.org/library/papers/25492846 | PubMed |
| 24,421,400 | Structure and protective efficacy of the Staphylococcus aureus autocleaving protease EpiP. | FASEB J | 2014 | https://conductscience.org/library/papers/24421400 | PubMed |
| 23,571,853 | Genotypes and virulence genes in group B streptococcus isolated in the maternity hospital, Kuwait. | Med Princ Pract | 2013 | https://conductscience.org/library/papers/23571853 | PubMed |
| 20,697,258 | Progress in the development of effective vaccines to prevent selected gram-positive bacterial infections. | Am J Med Sci | 2010 | https://conductscience.org/library/papers/20697258 | PubMed |
| 19,506,013 | Human serum induces streptococcal c5a peptidase expression. | Infect Immun | 2009 | https://conductscience.org/library/papers/19506013 | PubMed |
| 19,401,597 | Surfome analysis as a fast track to vaccine discovery: identification of a novel protective antigen for Group B Streptococcus hypervirulent strain COH1. | Mol Cell Proteomics | 2009 | https://conductscience.org/library/papers/19401597 | PubMed |
| 19,257,847 | Understanding the regulation of Group B Streptococcal virulence factors. | Future Microbiol | 2009 | https://conductscience.org/library/papers/19257847 | PubMed |
| 16,988,251 | High-affinity interaction between fibronectin and the group B streptococcal C5a peptidase is unaffected by a naturally occurring four-amino-acid deletion that eliminates peptidase activity. | Infect Immun | 2006 | https://conductscience.org/library/papers/16988251 | PubMed |
| 16,299,278 | Active and passive intranasal immunizations with streptococcal surface protein C5a peptidase prevent infection of murine nasal mucosa-associated lymphoid tissue, a functional homologue of human tonsils. | Infect Immun | 2005 | https://conductscience.org/library/papers/16299278 | PubMed |
| 16,138,188 | Anchors away: contribution of a glycolipid anchor to bacterial invasion of host cells. | J Clin Invest | 2005 | https://conductscience.org/library/papers/16138188 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/12379721
GET https://conductscience.org/api/papers/v1/12379721/references?page=2